Inceptionr LLC Takes $813,000 Position in Enovis Co. (NYSE:ENOV)

Inceptionr LLC bought a new stake in Enovis Co. (NYSE:ENOV - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 18,520 shares of the company's stock, valued at approximately $813,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. State of Alaska Department of Revenue lifted its stake in shares of Enovis by 20.8% during the 3rd quarter. State of Alaska Department of Revenue now owns 6,482 shares of the company's stock worth $279,000 after acquiring an additional 1,115 shares during the last quarter. US Bancorp DE increased its stake in Enovis by 29.1% in the third quarter. US Bancorp DE now owns 17,962 shares of the company's stock worth $773,000 after purchasing an additional 4,050 shares during the period. State of New Jersey Common Pension Fund D boosted its stake in shares of Enovis by 15.4% during the third quarter. State of New Jersey Common Pension Fund D now owns 43,404 shares of the company's stock valued at $1,869,000 after purchasing an additional 5,801 shares during the period. Diamond Hill Capital Management Inc. boosted its stake in shares of Enovis by 7.8% during the third quarter. Diamond Hill Capital Management Inc. now owns 3,004,694 shares of the company's stock valued at $129,352,000 after purchasing an additional 218,660 shares during the period. Finally, Chartwell Investment Partners LLC grew its holdings in shares of Enovis by 25.6% in the third quarter. Chartwell Investment Partners LLC now owns 201,652 shares of the company's stock worth $8,681,000 after purchasing an additional 41,089 shares during the last quarter. Hedge funds and other institutional investors own 98.45% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

Separately, Needham & Company LLC lowered their price objective on shares of Enovis from $65.00 to $64.00 and set a "buy" rating for the company in a research report on Thursday, February 27th.

Enovis Stock Up 4.0 %

Shares of ENOV stock traded up $1.41 during mid-day trading on Tuesday, hitting $36.92. The stock had a trading volume of 1,267,354 shares, compared to its average volume of 1,035,758. Enovis Co. has a 12-month low of $35.14 and a 12-month high of $62.79. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.27 and a quick ratio of 1.12. The firm's 50-day moving average is $43.90 and its two-hundred day moving average is $43.98. The firm has a market capitalization of $2.10 billion, a P/E ratio of -16.86 and a beta of 2.05.

Enovis (NYSE:ENOV - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported $0.98 EPS for the quarter, beating analysts' consensus estimates of $0.92 by $0.06. The business had revenue of $560.98 million for the quarter, compared to the consensus estimate of $555.14 million. Enovis had a negative net margin of 5.95% and a positive return on equity of 4.39%. On average, analysts predict that Enovis Co. will post 2.79 earnings per share for the current fiscal year.

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.